Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
AquaBounty Technologies
AQB
$4.68M
| $125K | ﹤0.01% |
+2,885
| New | +$130K |
|
|
CREG
3277
DELISTED
Smart Powerr
CREG
| $124K | ﹤0.01% |
441
+24
| +6% | +$7.51K |
|
3278
Caledonia Mining Corp
CMCL
$364M
| $123K | ﹤0.01% |
14,656
+168
| +1% | +$1.31K |
|
|
SGRP
3279
DELISTED
SPAR Group
SGRP
| $123K | ﹤0.01% |
94,800
+52,800
| +126% | +$60K |
|
|
AHPI
3280
DELISTED
Allied Healthcare Products
AHPI
| $123K | ﹤0.01% |
101,082
+3,442
| +4% | +$3.96K |
|
3281
Myomo
MYO
$38.6M
| $122K | ﹤0.01% |
13,464
+4,651
| +53% | +$74.1K |
|
3282
Tandy Leather Factory
TLF
$19.5M
| $122K | ﹤0.01% |
21,400
+1,000
| +5% | +$5.02K |
|
3283
Archrock
AROC
$6.21B
| $121K | ﹤0.01% |
12,100
-168,800
| -93% | -$1.57M |
|
3284
Liquidia Corp
LQDA
$7.72B
| $121K | ﹤0.01% |
28,197
-9,703
| -26% | -$38.9K |
|
3285
Seanergy Maritime Holdings
SHIP
$386M
| $121K | ﹤0.01% |
1,383
-57
| -4% | -$5.02K |
|
|
ATXI
3286
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
| $121K | ﹤0.01% |
+11
| New | +$76.9K |
|
|
MARK
3287
DELISTED
Remark Holdings, Inc.
MARK
| $121K | ﹤0.01% |
23,571
+2,690
| +13% | +$18.5K |
|
|
BCOM
3288
DELISTED
B Communications Ltd
BCOM
| $121K | ﹤0.01% |
67,516
+4,700
| +7% | +$7.3K |
|
3289
Dyadic International
DYAI
$39M
| $120K | ﹤0.01% |
+23,200
| New | +$139K |
|
3290
Cerus
CERS
$579M
| $119K | ﹤0.01% |
+28,266
| New | +$122K |
|
|
EVLO
3291
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $119K | ﹤0.01% |
1,460
+735
| +101% | +$82.2K |
|
3292
CBAK Energy Technology Ltd
CBAT
$43.9M
| $118K | ﹤0.01% |
102,766
-12,854
| -11% | -$9.3K |
|
|
JG
3293
Aurora Mobile
JG
$31.5M
| $118K | ﹤0.01% |
2,006
+1,035
| +107% | +$68.3K |
|
3294
VOC Energy
VOC
$49.5M
| $118K | ﹤0.01% |
+25,521
| New | +$123K |
|
|
ACCS
3295
ACCESS Newswire
ACCS
$26.4M
| $118K | ﹤0.01% |
+10,101
| New | +$113K |
|
|
NHLD
3296
DELISTED
National Holdings Corporation
NHLD
| $118K | ﹤0.01% |
46,203
+2,900
| +7% | +$7.75K |
|
3297
TDH Holdings
PETZ
$12.2M
| $115K | ﹤0.01% |
4,256
-765
| -15% | -$22.9K |
|
|
GSV
3298
DELISTED
Gold Standard Ventures Corp.
GSV
| $114K | ﹤0.01% |
+132,684
| New | +$99.5K |
|
3299
CLPS Inc
CLPS
$24.5M
| $113K | ﹤0.01% |
22,500
+6,700
| +42% | +$27.1K |
|
3300
Sutro Biopharma
STRO
$411M
| $113K | ﹤0.01% |
+1,030
| New | +$106K |
|
Similar funds
Renaissance Technologies's Q4 2019 Portfolio in Review
As of Q4 2019, Renaissance Technologies held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Renaissance Technologies's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Renaissance Technologies's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Renaissance Technologies fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Renaissance Technologies's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Renaissance Technologies opened 518 new positions and closed 443 in Q4 2019.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.